JENNIFER HENNON: Open Payments
NPI 1316621436 · ROCK SPRING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 29 payments from 12 companies in 2025. Trend: 2023 $131 · 2024 $427 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $159 |
| PFIZER INC. | 4 | $86 |
| Astellas Pharma US Inc | 3 | $71 |
| Lilly USA, LLC | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| SANOFI PASTEUR INC. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
Products named: Ozempic, Veozah, ELIQUIS, Wegovy, MOUNJARO, Auvelity, VRAYLAR, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
